Costa Rica vs Iran: Patent applications, nonresidents
Patent applications, nonresidents over time
- Costa Rica
- Iran
How they compare
Iran currently reports 581 against 566 in Costa Rica, a difference of 15.
The two have swapped places 6 times across 40 shared years of data; in 1980 it was Iran ahead.
Costa Rica ranks 43rd and Iran ranks 40th of 150 countries.
Iran has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Costa Rica | Iran | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 52.67 | 267.78 | 215.11 | Iran |
| 1990s | 99.8 | 161.5 | 61.7 | Iran |
| 2000s | 391.2 | 407.4 | 16.2 | Iran |
| 2010s | 541.89 | 566.22 | 24.33 | Iran |
| 2020s | 545 | 607.5 | 62.5 | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher patent applications, nonresidents, Costa Rica or Iran?
- Iran, at 581 against 566 in Costa Rica as of 2021.
- What is the difference in patent applications, nonresidents between Costa Rica and Iran?
- 15, with Iran ahead.
- How many years of comparable data are there for Costa Rica and Iran?
- 40 years are reported by both, from 1980 to 2021.
- How do Costa Rica and Iran rank globally for patent applications, nonresidents?
- Costa Rica ranks 43rd and Iran ranks 40th of 150 countries.
- Where does this data come from?
- WIPO Patent Report: Statistics on Worldwide Patent Activity, World Intellectual Property Organization (WIPO), note: The International Bureau of WIPO assumes no responsibility with respect to the trans, published as Patent applications, nonresidents. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Patent applications are worldwide patent applications filed through the Patent Cooperation Treaty procedure or with a national patent office for exclusive rights for an invention--a product or process that provides a new way of doing something or offers a new technical solution to a problem. A patent provides protection for the invention to the owner of the patent for a limited period, generally 20 years.